Monday, January 23, 2017

UPDATE 2-Actelion drug fails trial, denting revenue potential

* Shares pare losses after falling more than 1 pct

(Adds comment from analyst, shares)

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)